Biotech company creates 20 jobs
A BIOTECH company is creating 20 jobs as it launches the commercial roll-out of its tracking system used in cell therapy and regenerative medicine clinical trials.
It follows the successful evaluation of Cardiff-based TrakCel’s software platform by GlaxoSmithKline (GSK), which has adopted the technology along with other leaders in the cell therapy industry.
The company, which will create the jobs over the next two years, has been supported by £125,000 business finance from the Welsh Government to help upscale its operation as it moves from R&D to commercialisation.
TrakCel currently employs 15 people including biotechnology specialists, software designers and technical support experts.
Its pioneering cell therapy process management and supply chain integration technology has been developed over the past three years to meet the highly specialised data management, reporting and analysis needs of complex clinical trials.
TrakCel’s software is designed to ensure that the right patient gets the right therapy at the right time and location.
It incorporates technologies such as biometrics and radio frequency identification, records and documents the transport and temperature of personalised regenerative and cell-based therapies and coordinates logistics between manufacturing sites and treatment sites in real time.
“This funding will help us acquire the resources we need to further develop our technology from our corporate headquarters in Cardiff,” said Keren Winmill, chair and CEO of TrakCel.
“With considerable interest from major pharmaceutical companies in the US and UK, the timing of the funding will also benefit commercial growth as we expand into the global market.”
In addition to GSK, TrakCel has secured contracts with other recognised companies including PCT Caladrius, Autolus and The Cell Therapy Catapult.
Last month TrakCel launched its Connected Services programme which aims to accelerate cell therapy success by enhancing TrakCel’s platform with links to participant firms that specialise in logistics, cell therapy manufacturing, patient treatment, storage, compliance and other essential tasks in the supply chain.